An accessible reference text to help clinicians in all relevant specialties understand how to diagnose and manage the conditions of pulmonary hypertension and pulmonary areterial hypertension, including information on when and whom to refer patients to.
An accessible reference text to help clinicians in all relevant specialties understand how to diagnose and manage the conditions of pulmonary hypertension and pulmonary areterial hypertension, including information on when and whom to refer patients to.Hinweis: Dieser Artikel kann nur an eine deutsche Lieferadresse ausgeliefert werden.
Clive Handler BSc, MD, MRCP, FACC FESC qualified from Guy's Hospital Medical School. He trained in cardiology at Guy's Hospital and at University College and Middlesex Hospitals. He was consultant Cardiologist at Northwick Park and St Mary's Hospitals and is now consultant in pulmonary hypertension in the National Pulmonary Hypertension Unit, Royal Free Hospital, London, and Honorary Consultant Cardiologist at Guy's and St Thomas' Hospitals and Honorary Senior Lecturer in Medicine, University College London, Medical School. He also works at both Highgate Hospital and the Hospital of St John and St Elizabeth.
Inhaltsangabe
* 1: History of pulmonary hypertension and the circulation * 2: Definitions of pulmonary hypertension and pulmonary arterial hypertension * 3: Clinical classification of pulmonary hyptertension * 4: Pathology of pulmonary hyptertension * 5: Pathology of chronic thromboembolic pulmonary hypertension * 6: Pathobiology of pulmonary arterial hypertension * 7: Inflammation, growth factors and thrombosis in pulmonary arterial hypertension * 8: Genetics and genomics of pulmonary arterial hypertension * 9: Epidemiology of pulmonary arterial hypertension and pulmonary hypertension * 10: Risk factors for pulmonary arterial hypertension * 11: Pathophysiology of pulmonary hypertension in non-pulmonary arterial hypertension groups * 12: Pulmonary arterial hypertension associated with connective tissue diseases * 13: Systemic sclerosis * 14: Systemic lupus erythematosus * 15: Sjögren's syndrome * 16: Polymyositis and dermatomyositis * 17: HIV * 18: Porto-pulmonary hypertension * 19: Venous thromboembolism and acute pulmonary embolism * 20: Acute pulmonary embolism * 21: Chronic thromboembolic pulmonary hypertension * 22: Pulmonary hypertension associated with congenital systemic-to-pulmonary cardiac shunts * 23: Schistomiasis * 24: Chronic haemolytic anaemias and pulmonary arterial hypertension * 25: Interstitial lung disease and pulmonary hypertension * 26: Prognosis of pulmonary arterial hypertension * 27: The right ventricle * 28: Clinical features of pulmonary arterial hypertension * 29: Haemodynamics and treatment approaches in pulmonary hypertension due to left heart disease * 30: Diagnostic algorithm * 31: Simple investigations * 32: Ventilation/perfusion scanning * 33: Echocardiography * 34: Non-invasive exercise testing * 35: Cardiac catheterisation * 36: Management of pulmonary arterial hypertension * 37: General measures * 38: Contraception in pulmonary arterial hypertension * 39: Risks of pregnancy and contraception * 40: Lifestyle issues * 41: Elective surgery in patients with pulmonary arterial hypertension * 42: Supportive therapy * 43: Management of arrhythmias * 44: Advanced therapies for pulmonary arterial hypertension * 45: Endothelin and endothelin receptor antagonists * 46: Phosphodiesterase-5 inhibitors * 47: Classes of recommendations for procedures and treatments * 48: Drug interactions with pulmonary arterial hypertension targeted therapies * 49: Combination therapy in pulmonary arterial hypertension * 50: Problems in conducting pulmonary arterial hypertension drug trials * 51: Atrial septostomy * 52: Translation
* 1: History of pulmonary hypertension and the circulation * 2: Definitions of pulmonary hypertension and pulmonary arterial hypertension * 3: Clinical classification of pulmonary hyptertension * 4: Pathology of pulmonary hyptertension * 5: Pathology of chronic thromboembolic pulmonary hypertension * 6: Pathobiology of pulmonary arterial hypertension * 7: Inflammation, growth factors and thrombosis in pulmonary arterial hypertension * 8: Genetics and genomics of pulmonary arterial hypertension * 9: Epidemiology of pulmonary arterial hypertension and pulmonary hypertension * 10: Risk factors for pulmonary arterial hypertension * 11: Pathophysiology of pulmonary hypertension in non-pulmonary arterial hypertension groups * 12: Pulmonary arterial hypertension associated with connective tissue diseases * 13: Systemic sclerosis * 14: Systemic lupus erythematosus * 15: Sjögren's syndrome * 16: Polymyositis and dermatomyositis * 17: HIV * 18: Porto-pulmonary hypertension * 19: Venous thromboembolism and acute pulmonary embolism * 20: Acute pulmonary embolism * 21: Chronic thromboembolic pulmonary hypertension * 22: Pulmonary hypertension associated with congenital systemic-to-pulmonary cardiac shunts * 23: Schistomiasis * 24: Chronic haemolytic anaemias and pulmonary arterial hypertension * 25: Interstitial lung disease and pulmonary hypertension * 26: Prognosis of pulmonary arterial hypertension * 27: The right ventricle * 28: Clinical features of pulmonary arterial hypertension * 29: Haemodynamics and treatment approaches in pulmonary hypertension due to left heart disease * 30: Diagnostic algorithm * 31: Simple investigations * 32: Ventilation/perfusion scanning * 33: Echocardiography * 34: Non-invasive exercise testing * 35: Cardiac catheterisation * 36: Management of pulmonary arterial hypertension * 37: General measures * 38: Contraception in pulmonary arterial hypertension * 39: Risks of pregnancy and contraception * 40: Lifestyle issues * 41: Elective surgery in patients with pulmonary arterial hypertension * 42: Supportive therapy * 43: Management of arrhythmias * 44: Advanced therapies for pulmonary arterial hypertension * 45: Endothelin and endothelin receptor antagonists * 46: Phosphodiesterase-5 inhibitors * 47: Classes of recommendations for procedures and treatments * 48: Drug interactions with pulmonary arterial hypertension targeted therapies * 49: Combination therapy in pulmonary arterial hypertension * 50: Problems in conducting pulmonary arterial hypertension drug trials * 51: Atrial septostomy * 52: Translation
Es gelten unsere Allgemeinen Geschäftsbedingungen: www.buecher.de/agb
Impressum
www.buecher.de ist ein Internetauftritt der Steintor 70. V V GmbH (zukünftig firmierend: buecher.de internetstores GmbH)
Geschäftsführung: Monica Sawhney | Roland Kölbl
Sitz der Gesellschaft: Hannover
Amtsgericht Hannover HRB 227001
Steuernummer: 321/neu
